LA DORIA S.p.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:LA DORIA S.p.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3864
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

LA DORIA S.p.A. – Strategy, SWOT and Corporate Finance Report
Summary

LA DORIA S.p.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

LA Doria S.p.A. (Doria) manufactures food and beverages. The company is involved in processing, producing and marketing of tomato-based products, fruit juice, canned vegetables, pasta, pulses, nectars, extra virgin olive oil, hard cheese and fruit juice beverages. The company markets its products under the brands of La Doria, La Romanella, Vivi G, Vivi G Bio and Cook Italian. The company operates through five production sites in Italy apart from two direct and five indirect subsidiaries in the UK, Japan, Australia and in Scandinavian countries. It operates two subsidiaries: LDH (La Doria) Ltd and Eugea Mediterranea S.p.A. Doria is headquartered in Angri, Salerno, Italy.

Scope

- Detailed information on LA DORIA S.p.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting LA DORIA S.p.A. in the form of a SWOT analysis
- An in-depth view of the business model of LA DORIA S.p.A. including a breakdown and examination of key business segments
- Intelligence on LA DORIA S.p.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about LA DORIA S.p.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of LA DORIA S.p.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess LA DORIA S.p.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on LA DORIA S.p.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
LA DORIA S.p.A.: Company Overview 6
LA DORIA S.p.A.: Overview and Key Facts 6
LA DORIA S.p.A.: Overview 6
LA DORIA S.p.A.: Key Facts 6
LA DORIA S.p.A.: Key Employees 8
LA DORIA S.p.A.: Key Employee Biographies 9
LA DORIA S.p.A.: Major Products and Services 10
LA DORIA S.p.A.: Company History 11
LA DORIA S.p.A.: Management Statement 13
LA DORIA S.p.A.: Locations and Subsidiaries 16
LA DORIA S.p.A.: Key Competitors 17
LA DORIA S.p.A.: Company Analysis 18
LA DORIA S.p.A.: Business Description 18
LA DORIA S.p.A.: SWOT Analysis 19
LA DORIA S.p.A.: SWOT Overview 19
LA DORIA S.p.A.: Strengths 19
LA DORIA S.p.A.: Weaknesses 20
LA DORIA S.p.A.: Opportunities 20
LA DORIA S.p.A.: Threats 21
LA DORIA S.p.A.: Recent Developments 22
LA DORIA S.p.A.: News and Events Summary 22
LA DORIA S.p.A.: Financial Performance 22
Appendix 23
Contact Us 23
Methodology 23
About MarketLine 24

List of Tables
Table 1: LA DORIA S.p.A.: Key Facts
Table 2: LA DORIA S.p.A.: Key Employees
Table 3: LA DORIA S.p.A.: Locations and Subsidiaries
Table 4: LA DORIA S.p.A.: Key Competitors
Table 5: LA DORIA S.p.A.: News and Events Summary
Table 6: LA DORIA S.p.A.: Financial Performance



★海外企業調査レポート[LA DORIA S.p.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vectura Group Plc (VEC):医療機器:M&Aディール及び事業提携情報
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • Prakash Constrowell Limited:企業の戦略・SWOT・財務分析
    Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report Summary Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Rio Tinto Coal Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Rio Tinto Coal Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Rio Tinto Coal Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Abengoa SA (ABG):電力:M&Aディール及び事業提携情報
    Summary Abengoa SA (Abengoa) is an applied engineering and equipment manufacturer. It employs novel technological solutions for sustainability in infrastructures, energy and water sectors. The company provides integrated project solutions. Abengoa’s solutions include engineering, and operation and m …
  • Channel Four Telivision Corp:企業の戦略的SWOT分析
    Channel Four Telivision Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Tandem Diabetes Care Inc (TNDM):企業の製品パイプライン分析2018
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect applicat …
  • Caladrius Biosciences Inc (CLBS):製薬・医療:M&Aディール及び事業提携情報
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a cell therapy service provider. The company offers multiple technology platforms targeting cardiovascular indications and autoimmune diseases. It offers products to target type one diabetes mellitus, used to treat imbalance in …
  • Gland Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …
  • Ocugen Inc (OCGN):企業の財務・戦略的SWOT分析
    Summary Ocugen Inc (Ocugen), formerly Histogenics Corp, is a biopharmaceutical company that discovers, develops and commercializes transformative drugs for the treatment of eye diseases. The company’s lead product candidate, OCU300, is a small molecule therapeutic intended for the treatment of ocula …
  • PLx Pharma Inc (PLXP):製薬・医療:M&Aディール及び事業提携情報
    Summary PLx Pharma Inc (PLx Pharma) is a pharmaceutical company that develops patent-protected delivery systems. The company offers products such as PLxGuard delivery system, PLxGuard pipeline products, and PL1100 and PL1200 ibuprofen products. Its PLxGuard delivery system are used in enhancement of …
  • Midsona AB (MSON B):企業の財務・戦略的SWOT分析
    Summary Midsona AB (Midsona), is a healthcare products manufacturing company that provides personal care products, health foods, and hygiene products. The company’s products include superfood, sports nutrition, dietary supplements, nutritional supplements, organic food, herbal teas, skin-care and be …
  • Nipro Corp (8086):製薬・医療:M&Aディール及び事業提携情報
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary …
  • SGS SA (SGSN):石油・ガス:M&Aディール及び事業提携情報
    Summary SGS SA (SGS) is a provider of inspection, verification, testing, certification and quality assurance services. The company also provides risk management, consultancy, sustainability solutions and training services. SGS inspects, samples, analyzes, and monitors raw materials, components and p …
  • Advanced Biological Laboratories SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Advanced Biological Laboratories SA (ABL) is a medical data technology company that provides integrated software solutions for personalised medicine. The company offers TherapyEdge, a point of care, decision support software for healthcare professionals; and TherapyEdge Box systems, a web ba …
  • Orange and Rockland Utilities, Inc.:企業の戦略的SWOT分析
    Orange and Rockland Utilities, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • The Procter & Gamble Co:企業のM&A・事業提携・投資動向
    The Procter & Gamble Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Procter & Gamble Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • ReCor Medical Inc-医療機器分野:企業M&A・提携分析
    Summary ReCor Medical Inc (ReCor Medical) is a medical device company that designs and manufactures a proprietary ultrasound ablation system for performing renal denervation. The company provides technology such as Percutaneous Renal Denervation System (Paradise), a therapeutic non-focused ultrasoun …
  • French National Institute of Health and Medical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immu …
  • BB Biotech AG (BION):企業の財務・戦略的SWOT分析
    Summary BB Biotech AG (BB Biotech) operates as a financial service provider that offers biotechnology investments. The company invests in markets that develop new drugs and therapies for use in the treatment of autoimmune and infectious diseases, oncology disorders, cardiovascular diseases, and meta …
  • AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析
    AES Gener SA (AESGENER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆